Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Ureas derivative and application thereof in preventing and treating inflammation

A technology of derivatives and ureas, applied in the field of urea derivatives and their application in the prevention and treatment of inflammation

Inactive Publication Date: 2018-09-28
王若锴
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

mPGES-1 was discovered in 1999. It is located at the end of the prostaglandin inflammatory mediator production pathway, and its expression is only up-regulated under the induction of inflammation. mPGES-1 is considered to be an inflammatory drug target that can avoid toxic side effects. mPGES-1 inhibitors enter clinical trials

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Ureas derivative and application thereof in preventing and treating inflammation
  • Ureas derivative and application thereof in preventing and treating inflammation
  • Ureas derivative and application thereof in preventing and treating inflammation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1: Synthesis of 1-hydroxyl-1-(2-(3-nitrophenyl)-2,3-dihydro-1H-inden-1-yl)urea

[0027] Synthesis of 1-1,2-bromo-2,3-dihydro-1H-inden-1-ylmethanesulfonic acid:

[0028]

[0029] To a solution of 2-bromo-2,3-dihydro-1H-inden-1-ol (10.0 g, 46.93 mmol), triethylamine (10.8 g, 106.73 mmol) in DCM (50 mL) at 0 °C was added dropwise Methanesulfonyl chloride MsCl (9.9 g, 86.43 mmol) was added dropwise over 30 minutes. The mixture was stirred for an additional 2 hours, then allowed to warm to room temperature. Water (50 mL) was added, the DCM layer was separated and the aqueous phase was extracted twice more with DCM (2 x 30 mL). The combined organic phases were washed with brine (50 mL), then washed with Na 2 SO 4 dry. The solvent was removed under vacuum to give 2-bromo-2,3-dihydro-1H-inden-1-ylmethanesulfonic acid as a light oil, yield 13.53 g, 99% yield, which was directly obtained without further purification for the next step. 1 H-NMR (400MHz, CDCl3) δ: ...

Embodiment 2

[0039] Example 2: Synthesis of 1-hydroxyl-1-(2-(3-fluoro-phenyl)-2,3-dihydro-1H-inden-1-yl)urea:

[0040]

[0041] 1-(2-Bromo-2,3-dihydro-1H-inden-1-yl)-1-hydroxyurea (10.77 g, 39.73 mmol) was dissolved in 96 mL of H 2 O:EtOH (1:1) mixture and placed in a three-necked flask (250mL). 3-Fluoro-phenylboronic acid (55.47 mmol) and potassium carbonate (8.29 g, 59.99 mmol) were added to the mixture. Then PdNPs catalyst (0.4 mmol% Pd) was added, and the mixture was vigorously stirred at 60 °C for 10 min under nitrogen atmosphere. The reaction mixture was added to 0.2 mol / L sodium hydroxide solution (55 mL) and extracted with ethyl acetate (40 mL). The organic layers were combined and crystallized by volatilization in air to give the solid product 1-hydroxy-1-(2-(3-fluoro-phenyl)-2,3-dihydro-1H-inden-1-yl)urea, 10.45 g, the yield was 92%. LC-MS (ESI, pos, ion) m / z: 287 [M+H].

Embodiment 3

[0042] Example 3: Synthesis of 1-hydroxyl-1-(2-phenyl-2,3-dihydro-1H-inden-1-yl)urea:

[0043]

[0044] 1-(2-Bromo-2,3-dihydro-1H-inden-1-yl)-1-hydroxyurea (10.77 g, 39.73 mmol) was dissolved in 96 mL of H 2 O:EtOH (1:1) mixture and placed in a three-necked flask (250mL). Phenylboronic acid (55.47 mmol) and potassium carbonate (8.29 g, 59.99 mmol) were added to the mixture. Then PdNPs catalyst (0.4 mmol% Pd) was added, and the mixture was vigorously stirred at 60 °C for 10 min under nitrogen atmosphere. The reaction mixture was added to 0.2 mol / L sodium hydroxide solution (55 mL) and extracted with ethyl acetate (40 mL). The organic layers were combined and crystallized by volatilization in air to obtain the solid product 1-hydroxyl-1-(2-phenyl-2,3-dihydro-1H-inden-1-yl)urea, 9.05g, with a yield of 85 %. LC-MS (ESI, pos, ion) m / z: 269 [M+H].

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a ureas derivative and application thereof in preventing and treating inflammation. R1, R2 and R3 are respectively and independently selected from H, F or NO2. The in vitro activity measuring result shows that the compound has 5-lipoxygenase inhibitory activity and prostaglandin E synthetase inhibitory activity and can be used as a medicine for treating inflammation and forfurther carrying out thorough and extensive study, and the inflammation can be gynecology inflammation, hepatitis, myocarditis, encephalitis, nephritis, pneumonia, trachitis, pharyngitis, periodontitis, gastritis, enteritis and the like.

Description

technical field [0001] The invention belongs to the field of chemical medicine and relates to a urea derivative and its application in preventing and treating inflammation. Background technique [0002] Inflammation refers to the defense response of living tissue with vascular system to injury factors. Vascular responses are central to the inflammatory process. Inflammation, which is commonly referred to as "inflammation", is a defense response of the body to stimuli, manifested as redness, swelling, heat, pain and dysfunction. Inflammation can be infectious inflammation caused by infection, or non-infectious inflammation not caused by infection. Normally, inflammation is beneficial and is the body's automatic defense response, but sometimes it is also harmful, such as attacks on the body's own tissues, inflammation in transparent tissues, and so on. In the inflammatory process, on the one hand, the damage factors directly or indirectly cause tissue and cell destruction, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C273/18C07C275/64A61K31/17A61P29/00
CPCA61P29/00C07C275/64
Inventor 王若锴
Owner 王若锴
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com